Correlation Between Pharvaris and Curis
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Curis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Curis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Curis Inc, you can compare the effects of market volatilities on Pharvaris and Curis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Curis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Curis.
Diversification Opportunities for Pharvaris and Curis
Poor diversification
The 3 months correlation between Pharvaris and Curis is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Curis Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Curis Inc and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Curis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Curis Inc has no effect on the direction of Pharvaris i.e., Pharvaris and Curis go up and down completely randomly.
Pair Corralation between Pharvaris and Curis
Given the investment horizon of 90 days Pharvaris BV is expected to generate 0.79 times more return on investment than Curis. However, Pharvaris BV is 1.26 times less risky than Curis. It trades about 0.05 of its potential returns per unit of risk. Curis Inc is currently generating about -0.02 per unit of risk. If you would invest 832.00 in Pharvaris BV on November 27, 2024 and sell it today you would earn a total of 748.00 from holding Pharvaris BV or generate 89.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pharvaris BV vs. Curis Inc
Performance |
| Timeline |
| Pharvaris BV |
| Curis Inc |
Pharvaris and Curis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pharvaris and Curis
The main advantage of trading using opposite Pharvaris and Curis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Curis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Curis will offset losses from the drop in Curis' long position.| Pharvaris vs. Pmv Pharmaceuticals | Pharvaris vs. MediciNova | Pharvaris vs. PepGen | Pharvaris vs. Molecular Partners AG |
| Curis vs. Artelo Biosciences | Curis vs. X4 Pharmaceuticals | Curis vs. Mereo BioPharma Group | Curis vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |